NEW YORK, Nov. 18 (GenomeWeb News) - Celgene and Galapagos Genomics today announced a multi-year target discovery collaboration.


Under terms of the agreement, Galadeno, Galapagos' wholly owned services unit, will provide Celgene with its adenoviral SilenceSelect siRNA and FleXSelect cDNA libraries.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.